ConductScience.org, home

Paper48833

Plasma exchange in the management of homozygous familial hypercholesterolaemia.

Thompson GR and 2 others. Lancet, 1975. Cited by 330 papers, by iCite.

Cite this record

ConductScience Library. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Papers, record 48833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/48833

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma exchange in the management of homozygous familial hypercholesterolaemia.
PubMed
Journal
Lancet
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
330
iCite
Relative citation ratio, by iCite
10.8
iCite
Revised in PubMed
2019-06-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thompson GRG R
2Lowenthal RR
3Myant NBN B

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HyperlipidemiasMajor topic
PlasmapheresisMajor topic
Adult
Aortic Diseases
Arteriosclerosis
Cholesterol
Cholestyramine Resin
Clofibrate
Coronary Disease
Female
Homozygote
Humans
Lipoproteins, HDL
Lipoproteins, LDL
Nicotinic Acids

Source PubMed

Download CSV of topics

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 330 citations.

PMIDTitleJournalYearIn PapersSource
42798794Is FH a curable disease?Glob Cardiol Sci Pract2026https://conductscience.org/library/papers/42798794PubMed
42796005Real-World Outcomes of Lipoprotein Apheresis in Homozygous Familial Hypercholesterolemia: A Single-Center Longitudinal Experience.J Clin Med2026https://conductscience.org/library/papers/42796005PubMed
4199823150 years of apheresis for homozygous familial hypercholesterolemia.Nat Cardiovasc Res2026https://conductscience.org/library/papers/41998231PubMed
41369603Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia.JACC Case Rep2026https://conductscience.org/library/papers/41369603PubMed
38541699Novel Therapeutic Approaches for the Management of Elevated Lipoprotein(a): From Traditional Agents to Future Treatment Options.Life (Basel)2024https://conductscience.org/library/papers/38541699PubMed
37273067Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a).Curr Atheroscler Rep2023https://conductscience.org/library/papers/37273067PubMed
36701088Apheresis: What Should a Clinician Know?Curr Atheroscler Rep2023https://conductscience.org/library/papers/36701088PubMed
36682773Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022.J Atheroscler Thromb2023https://conductscience.org/library/papers/36682773PubMed
35303294Contemporary Management of Dyslipidemia.Drugs2022https://conductscience.org/library/papers/35303294PubMed
34759397Extracorporeal Therapy in Dermatology.Indian J Dermatol2021https://conductscience.org/library/papers/34759397PubMed
32651185FH through the retrospectoscope.J Lipid Res2021https://conductscience.org/library/papers/32651185PubMed
31041550Current Role of Lipoprotein Apheresis.Curr Atheroscler Rep2019https://conductscience.org/library/papers/31041550PubMed
30050433Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management.Front Pharmacol2018https://conductscience.org/library/papers/30050433PubMed
29877295Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.J Atheroscler Thromb2018https://conductscience.org/library/papers/29877295PubMed
28185213Hyperlipoproteinaemia(a) - apheresis and emerging therapies.Clin Res Cardiol Suppl2017https://conductscience.org/library/papers/28185213PubMed
27416572The Italian Consensus Conferences on low density lipoprotein-cholesterol apheresis.Blood Transfus2017https://conductscience.org/library/papers/27416572PubMed
26889050Lipoprotein apheresis to treat elevated lipoprotein (a).J Lipid Res2016https://conductscience.org/library/papers/26889050PubMed
26201613Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment.Wien Klin Wochenschr2015https://conductscience.org/library/papers/26201613PubMed
26004920Lipoprotein apheresis.Curr Atheroscler Rep2015https://conductscience.org/library/papers/26004920PubMed
25670911The genetics of familial hypercholesterolemia and emerging therapies.Appl Clin Genet2015https://conductscience.org/library/papers/25670911PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/48833

GET https://conductscience.org/api/papers/v1/48833/cited_by?page=2